BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 31744889)

  • 1. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
    Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Plaikner A; Siegler K; Hertel H; Jacob A; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C
    Int J Gynecol Cancer; 2023 Oct; 33(10):1542-1547. PubMed ID: 37696645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
    Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
    Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm.
    Rendón GJ; Lopez Blanco A; Aragona A; Saadi JM; Di Guilmi J; Arab Eblen C; Heredia Muñoz F; Pareja R
    Int J Gynecol Cancer; 2021 Mar; 31(3):462-467. PubMed ID: 33199429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomy.
    Tsubamoto H; Kanazawa R; Inoue K; Ito Y; Komori S; Maeda H; Hirota S
    Int J Gynecol Cancer; 2012 Jul; 22(6):1057-62. PubMed ID: 22683943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
    Gwacham NI; McKenzie ND; Fitzgerald ER; Ahmad S; Holloway RW
    Gynecol Oncol; 2021 Sep; 162(3):809-815. PubMed ID: 34130862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.
    Plante M; van Trommel N; Lheureux S; Oza AM; Wang L; Sikorska K; Ferguson SE; Han K; Amant F
    Int J Gynecol Cancer; 2019 Jun; 29(5):969-975. PubMed ID: 31101688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
    Burbano J; Heredia F; Sanabria D; Ardila EG; Viveros-Carreño D; Rodriguez J
    Int J Gynecol Cancer; 2021 Mar; 31(3):387-398. PubMed ID: 33649006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.
    Lu Q; Zhang Y; Wang S; Guo S; Guo H; Zhang Z; Liu C
    Fertil Steril; 2014 Mar; 101(3):812-7. PubMed ID: 24439996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
    Viveros-Carreño D; Rodriguez J; Rendon Pereira GJ; Slama J; Halaska MJ; Robova H; Pareja R
    Int J Gynecol Cancer; 2022 Apr; 32(4):486-493. PubMed ID: 35210296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncological and pregnancy outcomes after high-dose density neoadjuvant chemotherapy and fertility-sparing surgery in cervical cancer.
    Robova H; Halaska MJ; Pluta M; Skapa P; Matecha J; Lisy J; Rob L
    Gynecol Oncol; 2014 Nov; 135(2):213-6. PubMed ID: 25159484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
    Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
    de Vincenzo R; Ricci C; Fanfani F; Gui B; Gallotta V; Fagotti A; Ferrandina G; Scambia G
    Fertil Steril; 2021 Jan; 115(1):148-156. PubMed ID: 33092819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers.
    Slama J; Fischerova D; Zikan M; Kocian R; Germanova A; Fruhauf F; Dusek L; Cibula D
    Int J Gynecol Cancer; 2017 Jan; 27(1):147-153. PubMed ID: 27668393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
    van Kol KGG; Vergeldt TFM; Bekkers RLM
    Gynecol Oncol; 2019 Dec; 155(3):515-521. PubMed ID: 31606284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature.
    Kuznicki ML; Chambers LM; Morton M; Son J; Horowitz M; Crean-Tate KK; Hackett L; Rose PG
    J Minim Invasive Gynecol; 2021 Mar; 28(3):513-526.e1. PubMed ID: 33223017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve-sparing radical abdominal trachelectomy versus nerve-sparing radical hysterectomy in early-stage (FIGO IA2-IB) cervical cancer: a comparative study on feasibility and outcome.
    van Gent MD; van den Haak LW; Gaarenstroom KN; Peters AA; van Poelgeest MI; Trimbos JB; de Kroon CD
    Int J Gynecol Cancer; 2014 May; 24(4):735-43. PubMed ID: 24651626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy followed by radical vaginal trachelectomy and adjuvant chemotherapy for clear cell cancer of the cervix: a feasible approach and review.
    Singh P; Nicklin J; Hassall T
    Int J Gynecol Cancer; 2011 Jan; 21(1):137-40. PubMed ID: 21178575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy after neoadjuvant chemotherapy for the IB1 cervical cancer: A series of 60 cases.
    Yan H; Liu Z; Fu X; Li Y; Che H; Mo R; Song L
    Int J Surg; 2016 May; 29():38-42. PubMed ID: 26975424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study.
    Slama J; Runnebaum IB; Scambia G; Angeles MA; Bahrehmand K; Kommoss S; Fagotti A; Narducci F; Matylevich O; Holly J; Martinelli F; Koual M; Kopetskyi V; El-Balat A; Corrado G; Căpîlna ME; Schröder W; Novàk Z; Shushkevich A; Fricová L; Cibula D
    Am J Obstet Gynecol; 2023 Apr; 228(4):443.e1-443.e10. PubMed ID: 36427596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.